Health Care: Drugs

Eli Lilly and Co (LLY: NYSE)

$82.09 0.11 | 0.13%
07/26/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 19.96B 19.62B 23.11B 22.60B
Cost of Sales 3.61B 3.55B 3.46B 3.33B
Gross Operating Profit 16.35B 16.06B 19.65B 19.27B
Selling, General, and Administrative Expenses 6.53B 6.62B 7.13B 7.51B
Research & Development 5.33B 4.73B 5.53B 5.28B
Operating Income before D & A (EBITDA) 4.48B 4.71B 6.99B 6.48B
Depreciation & Amortization 1.43B 1.38B 1.45B 1.46B
Interest Income 0.00 121.00M 119.70M 105.00M
Other Income - Net -267.10M -300.60M 559.30M 0.00
Special Income / Charges 0.00 0.00 -234.80M 465.70M
Total Income Before Interest Expenses (EBIT) 2.79B 3.15B 6.05B 5.59B
Interest Expense 0.00 148.80M 160.10M 177.80M
Pre-Tax Income 2.79B 3.00B 5.89B 5.41B
Income Taxes 381.60M 609.80M 1.20B 1.32B
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 2.41B 2.39B 4.68B 4.09B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.41B 2.39B 4.68B 4.09B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.41B 2.39B 4.68B 4.09B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.41B 2.39B 4.86B 3.62B
Preferred Dividends
Net Income Available To Common 2.41B 2.39B 4.68B 4.09B
Basic EPS from Continuing Ops. 2.27 2.23 4.33 3.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.27 2.23 4.33 3.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.27 2.23 4.33 3.67
Basic Normalized Net Income/Share 2.27 2.23 4.50 3.25
EPS fr Continuing Ops. 2.26 2.23 4.32 3.66
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.26 2.23 4.32 3.66
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.26 2.23 4.32 3.66
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.26 2.23 4.48 3.24
Dividends Paid per Share 2.00 1.96 1.96 1.96

Portfolios with LLY

Latest LLY Headlines from TheStreet

More Financial News for LLY

Press Releases for LLY

See All Press Releases

Partner Headlines for LLY

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter